Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: A Treatment Planning Study

Purpose The first stereotactic arrhythmia radioablation (STAR) of ventricular tachycardia (VT) was delivered at Stanford on a robotic radiosurgery system (CyberKnife® G4) in 2012. The results warranted further investigation of this treatment. Here we compare dosimetrically three possible treatment delivery platforms for STAR. Methods The anatomy and target volume of the first treated patient were used for this study. A dose of 25 Gy in one fraction was prescribed to the planning target volume (PTV). Treatment plans were created on three treatment platforms: CyberKnife® G4 system with Iris collimator (Multiplan, V. 4.6)(Plan #1), CyberKnife® M6 system with InCise 2TM multileaf collimator (Multiplan V. 5.3)(Plan #2) and Varian TrueBeamTM STx with HD 120TM MLC and 10MV flattening filter free (FFF) beam (Eclipse planning system, V.11) (Plan #3 coplanar and #4 noncoplanar VMAT plans). The four plans were compared by prescription isodose line, plan conformity index, dose gradient, as well as dose to the nearby critical structures. To assess the delivery efficiency, planned monitor units (MU) and estimated treatment time were evaluated. Results Plans #1-4 delivered 25 Gy to the PTV to the 75.0%, 83.0%, 84.3%, and 84.9% isodose lines and with conformity indices of 1.19, 1.16, 1.05, and 1.05, respectively. The dose gradients for plans #1-4 were 3.62, 3.42, 3.93, and 3.73 with the CyberKnife® MLC plan (Plan #2) the best, and the TrueBeamTM STx co-planar plan (Plan #3) the worst. The dose to nearby critical structures (lung, stomach, bowel, and esophagus) were all well within tolerance. The MUs for plans #1-4 were 27671, 16522, 6275, and 6004 for an estimated total-treatment-time/beam-delivery-time of 99/69, 65/35, 37/7, and 56/6 minutes, respectively, under the assumption of 30 minutes pretreatment setup time. For VMAT gated delivery, a 40% duty cycle, 2400MU/minute dose rate, and an extra 10 minutes per extra arc were assumed. Conclusion Clinically acceptable plans were created with all three platforms. Plans with MLC were considerably more efficient in MU. CyberKnife® M6 with InCise 2TM collimator provided the most conformal plan (steepest dose drop-off) with significantly reduced MU and treatment time. VMAT plans were most efficient in MU and delivery time. Fluoroscopic image guidance removes the need for additional fiducial marker placement; however, benefits may be moderated by worse dose gradient and more operator-dependent motion management by gated delivery.

[1]  B. Heijmen,et al.  Characteristics and performance of the first commercial multileaf collimator for a robotic radiosurgery system. , 2016, Medical physics.

[2]  G. Kalantzis,et al.  Dosimetric and radiobiological comparison of CyberKnife M6™ InCise multileaf collimator over IRIS™ variable collimator in prostate stereotactic body radiation therapy , 2016, Journal of medical physics.

[3]  Calvin R. Maurer,et al.  The design and physical characterization of a multileaf collimator for robotic radiosurgery , 2016 .

[4]  Lu Wang,et al.  Dosimetric and delivery efficiency investigation for treating hepatic lesions with a MLC-equipped robotic radiosurgery-radiotherapy combined system. , 2016, Medical physics.

[5]  B. Fahimian,et al.  First In-Human Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: Dynamic Tracking Delivery Analysis and Implications , 2015 .

[6]  Jean Pouliot,et al.  Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients , 2015, Journal of applied clinical medical physics.

[7]  Paul C. Zei,et al.  Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. , 2015, Circulation. Arrhythmia and electrophysiology.

[8]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[9]  Paul C. Zei,et al.  Cardiac Radiosurgery (CyberHeart™) for Treatment of Arrhythmia: Physiologic and Histopathologic Correlation in the Porcine Model , 2011 .

[10]  Huanmei Wu,et al.  Correlation and prediction uncertainties in the cyberknife synchrony respiratory tracking system. , 2011, Medical physics.

[11]  P. Plowman,et al.  CyberKnife radiosurgery for an intracardiac metastasis , 2011, BMJ Case Reports.

[12]  Motion management and image guidance for thoracic tumor radiotherapy: clinical treatment programs. , 2011, Frontiers of radiation therapy and oncology.

[13]  Arjun D. Sharma,et al.  Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. , 2010, Heart rhythm.

[14]  W Schlegel,et al.  The design, physical properties and clinical utility of an iris collimator for robotic radiosurgery , 2009, Physics in medicine and biology.

[15]  Steven D Chang,et al.  Stereotactic Radiosurgery for a Cardiac Sarcoma: A Case Report , 2008, Technology in cancer research & treatment.

[16]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[17]  John R. Adler,et al.  CYBERKNIFE RADIOSURGERY FOR TRIGEMINAL NEURALGIA TREATMENT: A PRELIMINARY MULTICENTER EXPERIENCE , 2008, Neurosurgery.

[18]  Jeremy N Ruskin,et al.  Prophylactic catheter ablation for the prevention of defibrillator therapy. , 2007, The New England journal of medicine.

[19]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.

[20]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[21]  William Main,et al.  An Analysis of the Accuracy of the CyberKnife: A Robotic Frameless Stereotactic Radiosurgical System , 2003, Neurosurgery.

[22]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[23]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[24]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.